tradingkey.logo

Transmedics Group Inc <TMDX.OQ> expected to post earnings of 26 cents a share - Earnings Preview

ReutersMay 6, 2025 10:07 PM
  • Transmedics Group Inc TMDX.OQ TMDX.O is expected to show a rise in quarterly revenue when it reports results on May 8 for the period ending March 31 2025

  • The Andover Massachusetts-based company is expected to report a 27.7% increase in revenue to $123.66 million from $96.85 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Transmedics Group Inc is for earnings of 26 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Transmedics Group Inc is $112.50​, above​ its last closing price of $93.38. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

0.20

0.16

0.19

Beat

18.8

Sep. 30 2024

0.29

0.29

0.12

Missed

-59.1

Jun. 30 2024

0.20

0.21

0.35

Beat

66.7​

Mar. 31 2024

-0.04

-0.04

0.35

Beat

975

​​Dec. 31 2023

-0.03

-0.06

0.12

Beat

293.5

Sep. 30 2023

-0.16

-0.16

-0.78

Missed

-382.5​

Jun. 30 2023

-0.11

-0.13

-0.03

Beat

76.9

Mar. 31 2023

-0.21

-0.25

-0.08

Beat

67.5

This summary was machine generated May 6 at 22:07 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI